Patil Neena M sold $278K of JAZZ
Patil Neena M (EVP & Chief Legal Officer) sold 1,200 shares of Jazz Pharmaceuticals plc (JAZZ) at $231.83 ($0.28M total) on 2026-06-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing confirms an officer’s scheduled open-market sale; absent any new company-specific news, it mainly informs sentiment/positioning rather than fundamentals.
Market read
A confirmed insider sale under a 10b5-1 plan; likely limited trading impact unless paired with other new catalysts.
What to watch
The article lacks context on total holdings, whether other insiders traded, and whether the plan size is part of a larger scheduled program.
Background
SEC Form 4 insider transaction for Jazz Pharmaceuticals (JAZZ) filed via EDGAR.
Ticker impact
Jazz Pharmaceuticals Form 4 shows EVP & Chief Legal Officer Neena M. Patil sold 1,200 shares on 2026-06-10 under a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The disclosure is an open-market sale by an officer under a pre-arranged Rule 10b5-1 plan, with no accompanying operational or financial catalyst in the text.
Market effects
No sector read-across; this is company-specific insider transaction reporting.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with executives de-risking ahead of personal liquidity needs; monitor for follow-on sales or buys.
Key entities
- issuerJazz Pharmaceuticals plc
Company whose insider transaction is disclosed on Form 4.
- insiderNeena M. Patil
EVP & Chief Legal Officer who sold 1,200 shares.
- trading mechanismRule 10b5-1 plan
Pre-arranged plan cited as the basis for the sale.
